4Q5-17159-91283
4 vaccinations
3 coded responses
51 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 595 / MT
- Registered
- 2021-07-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-19
Registered in v-safe
-
2021-07-19
Dose 1 — Pfizer-BioNTech
- 2021-07-19
- 2021-07-20
-
2021-07-21
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: Good · Site: PainFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2021-07-22
Survey response — days 1–6 daily, dose 1MedDRA: Respiratory tract congestion — Feeling: Good · DiarrheaFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
- 2021-07-24
- 2021-07-25
- 2021-07-26
- 2021-08-02
- 2021-08-09
-
2021-08-11
Dose 2 — Pfizer-BioNTech
- 2021-08-11
- 2021-08-12
- 2021-08-13
- 2021-08-14
- 2021-08-15
- 2021-08-16
- 2021-08-17
- 2021-08-18
- 2021-08-25
- 2021-09-01
- 2021-09-08
- 2021-09-15
- 2021-09-22
- 2021-11-10
- 2022-02-09
-
2022-04-08
Dose 3 — Pfizer-BioNTech
- 2022-04-08
- 2022-04-09
- 2022-04-10
- 2022-04-11
- 2022-04-12
- 2022-04-13
- 2022-04-15
- 2022-04-22
- 2022-04-29
- 2022-05-06
- 2022-05-13
- 2022-05-20
- 2022-07-10
-
2022-09-30
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-04
- 2022-10-05
- 2022-10-06
- 2022-10-07
- 2022-10-14
-
2022-10-21
Survey response — day 21, dose 4MedDRA: Headache, Rhinorrhoea, Sneezing — Feeling: Poor · Be unable to work or attend schoolFree text: Sneezing, runny nose, headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-10-28
- 2022-11-04
- 2022-11-11
- 2023-01-01
- 2023-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-19 | Pfizer-BioNTech | No |
| 2 | 2021-08-11 | Pfizer-BioNTech | No |
| 3 | 2022-04-08 | Pfizer-BioNTech | No |
| 4 | 2022-09-30 | Pfizer-BioNTech | Flu |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Runny nose
Systemic reaction (other): Congestion
Release 12 — day 21, dose 4
Symptoms: Sneezing, runny nose, headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release